| 20.04 0.02 (0.1%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 26.91 | 1-year : | 31.17 |
| Resists | First : | 23.04 | Second : | 26.69 |
| Pivot price | 20.64  |
|||
| Supports | First : | 17.14 | Second : | 14.26 |
| MAs | MA(5) : | 20.21 |
MA(20) : | 20.33 |
| MA(100) : | 25.28 |
MA(250) : | 45.59 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 31 |
D(3) : | 38.9 |
| RSI | RSI(14): 40.8 |
|||
| 52-week | High : | 76.51 | Low : | 17.14 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ DOCS ] has closed above bottom band by 29.7%. Bollinger Bands are 58% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 20.48 - 20.59 | 20.59 - 20.7 |
| Low: | 19.32 - 19.47 | 19.47 - 19.6 |
| Close: | 19.82 - 20.04 | 20.04 - 20.24 |
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Fri, 12 Jun 2026
Doximity: Cheaper, But Growth Is Still Missing (NYSE:DOCS) - Seeking Alpha
Fri, 12 Jun 2026
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Wed, 10 Jun 2026
Doximity (DOCS) interim PAO trades shares under 10b5-1 plan, exercises options - Stock Titan
Tue, 09 Jun 2026
[144] Doximity, Inc. SEC Filing - Stock Titan
Tue, 09 Jun 2026
Capital World Investors Has $250.40 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
Mon, 08 Jun 2026
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 132 (M) |
| Shares Float | 129 (M) |
| Held by Insiders | 2.8 (%) |
| Held by Institutions | 96.3 (%) |
| Shares Short | 15,660 (K) |
| Shares Short P.Month | 15,060 (K) |
| EPS | 0.98 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.19 |
| Profit Margin | 30.3 % |
| Operating Margin | 21.5 % |
| Return on Assets (ttm) | 11.6 % |
| Return on Equity (ttm) | 19.2 % |
| Qtrly Rev. Growth | 5 % |
| Gross Profit (p.s.) | 4.35 |
| Sales Per Share | 4.88 |
| EBITDA (p.s.) | 1.73 |
| Qtrly Earnings Growth | -69 % |
| Operating Cash Flow | 326 (M) |
| Levered Free Cash Flow | 255 (M) |
| PE Ratio | 20.44 |
| PEG Ratio | 0.5 |
| Price to Book value | 3.86 |
| Price to Sales | 4.1 |
| Price to Cash Flow | 8.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|